Predictors for short-term outcomes of patients undergoing transcatheter mitral valve interventions: Analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function

EuroIntervention

Volumn 12, Issue 4, 2016, Pages 508-514

  Schueler, Robert ^a   Nickenig, Georg ^a   May, Andreas E ^b   Schillinger, Wolfgang ^c   Bekeredjian, Raffi ^d   Ouarrak, Taoufik ^e   Schofer, Joachim ^f   Hehrlein, Christoph ^g   Sievert, Horst ^h   Boekstegers, Peter ⁱ   Lubos, Edith ^j   Hoffmann, Rainer ^k   Baldus, Stephan ^l   Senges, Jochen ^e   Hammerstingl, Christoph ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e Institut fuer Herzinfarktforschung   (Germany)

^f UNIVERSITY HEART CENTER HAMBURG   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h Cardiovascular Centre Frankfurt   (Germany)

ⁱ Heart Center Siegburg   (Germany)

^j UNIVERSITY OF HAMBURG   (Germany)

^k RWTH AACHEN UNIVERSITY   (Germany)

^l UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

MitraClip; Mitral regurgitation; Outcome; Renal function

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; EUROSCORE; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; IMPLANTABLE CLIP; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MORTALITY; PREVALENCE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TRANSCATHETER MITRAL VALVE REPAIR; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VERY ELDERLY; ADVERSE EFFECTS; GERMANY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PROCEDURES; REGISTER; RENAL INSUFFICIENCY; RISK FACTOR; TIME FACTOR;

AGED; AGED, 80 AND OVER; CARDIAC CATHETERIZATION; FEMALE; GERMANY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PROSPECTIVE STUDIES; REGISTRIES; RENAL INSUFFICIENCY; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84983035962     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY15M09_07     Document Type: Article

References (24)

1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-43.
2. Iung B, Vahanian A. Valvular heart diseases in elderly people. Lancet. 2006;368:969-71.
3. Feldman T, Ali O. Transcatheter mitral valve interventions: current status and future perspective. EuroIntervention. 2012;8 Suppl Q:Q53-9.
4. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395-406.
5. Schillinger W, Hunlich M, Baldus S, Ouarrak T, Boekstegers P, Hink U, Butter C, Bekeredjian R, Plicht B, Sievert H, Schofer J, Senges J, Meinertz T, Hasenfuss G. Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. EuroIntervention. 2013;9:84-90.
6. Baldus S, Schillinger W, Franzen O, Bekeredjian R, Sievert H, Schofer J, Kuck KH, Konorza T, Mollmann H, Hehrlein C, Ouarrak T, Senges J, Meinertz T; German Transcatheter Mitral Valve Interventions (TRAMI) investigators. MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2012;14:1050-5.
7. Maisano F, Franzen O, Baldus S, Schafer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62:1052-61.
8. Damman K, Valente MA, Voors AA, O'Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35:455-69.
9. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med. 2007;167:2490-6.
10. Holzmann MJ, Sartipy U. Relation between preoperative renal dysfunction and cardiovascular events (stroke, myocardial infarction, or heart failure or death) within three months of isolated coronary artery bypass grafting. Am J Cardiol. 2013;112:1342-6.
11. Holzmann MJ, Gardell C, Jeppsson A, Sartipy U. Renal dysfunction and long-term risk of heart failure after coronary artery bypass grafting. Am Heart J. 2013;166:142-9.
12. Sinning JM, Ghanem A, Steinhauser H, Adenauer V, Hammerstingl C, Nickenig G, Werner N. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3:1141-9.
13. Thourani VH, Keeling WB, Sarin EL, Guyton RA, Kilgo PD, Dara AB, Puskas JD, Chen EP, Cooper WA, Vega JD, Morris CD, Halkos ME, Lattouf OM. Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement. Ann Thorac Surg. 2011;91:1798-806.
14. Nakazato T, Nakamura T, Sekiya N, Sawa Y. Preoperative estimated glomerular filtration rate is an independent predictor of late cardiovascular morbidity after mitral valve surgery. Ann Thorac Cardiovasc Surg. 2014;20:390-7.
15. Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, Wang A, Whitlow PL, Gray WA, Grayburn P, Mack MJ, Glower D. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation following transcatheter mitral valve repair. J Am Coll Cardiol. 2014;64: 182-92.
16. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, Bajwa T, Herrmann HC, Lasala J, Maddux JT, Tuzcu M, Kapadia S, Trento A, Siegel RJ, Foster E, Glower D, Mauri L, Kar S; EVEREST II Investigators. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol. 2012;59: 130-9.
17. Gibson PH, Croal BL, Cuthbertson BH, Chiwara M, Scott AE, Buchan KG, El-Shafei H, Gibson G, Jeffrey RR, Hillis GS. The relationship between renal function and outcome from heart valve surgery. Am Heart J. 2008;156:893-9.
18. Hillis GS, Cuthbertson BH, Croal BL. Renal function, revascularization and risk. Eur Heart J. 2007;28:782-4.
19. Damman K, Voors AA, Navis G, van Veldhuisen DJ, Hillege HL. The cardiorenal syndrome in heart failure. Prog Cardiovasc Dis. 2011;54:144-53.
20. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004;109: 1004-9.
21. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113:671-8.
22. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102:203-10.
23. Maisano F, Franzen O, Baldus S, Schafer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62: 1052-61.
24. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987-96.